The North America aesthetic devices market share in 2026 is witnessing significant transformation as consumers increasingly seek minimally invasive and non-invasive cosmetic procedures. Aesthetic devices are used across a wide range of applications, including skin resurfacing and tightening, body contouring, cellulite reduction, hair and tattoo removal, and breast augmentation. Technological advancements, increasing demand for cosmetic procedures, and growing investments in aesthetic device development are contributing to the expansion of the market across the region.
According to Fortune Business Insights, the North America aesthetic devices market size was valued at USD 4.83 billion in 2020. The market is projected to grow from USD 5.38 billion in 2021 to USD 10.75 billion by 2028, registering a CAGR of 10.4% during the 2021-2028 period. The market experienced a significant impact from the COVID-19 pandemic, as restrictions on elective procedures and disruptions across healthcare services reduced demand for aesthetic devices.
The growing acceptance of aesthetic procedures has created new opportunities for manufacturers and healthcare providers. Aesthetic treatments have increasingly become part of routine personal care, while rising spending on cosmetic procedures is supporting market development. Demand for minimally invasive procedures, advancements in cosmetic technologies, increasing surgeries, and the rising incidence of congenital tooth and facial deformities are among the factors supporting market growth.
The introduction of innovative devices and increasing demand for minimally invasive procedures are major factors supporting the North America aesthetic devices market. Consumers increasingly prefer procedures that offer effective results with less pain and fewer complications than conventional invasive cosmetic surgeries. The growing demand for botulinum toxin, dermal fillers, body contouring, skin tightening, and other aesthetic procedures is encouraging manufacturers to increase their research and development activities.
Manufacturers are also developing advanced technologies for skin tightening and body contouring. For example, Asclepion Laser Technologies announced the BodyLab body shaping system in May 2021 for muscle toning and fat reduction using FMS technology. Such innovations are supporting the availability of non-invasive and pain-free treatment options.
However, high product costs and the potential risk of side effects may restrict market growth. Aesthetic procedures can involve complications such as hematoma, seroma, blood loss, infections, nerve damage, and scarring. The high cost and potential side effects associated with certain aesthetic treatments, including botulinum toxin, may also limit adoption.
The North America aesthetic devices market is characterized by a consolidated competitive landscape, with prominent companies focusing on product development, research and development, strategic collaborations, acquisitions, and distribution expansion. AbbVie Inc., Cynosure, and Candela Medical accounted for a significant market share in 2020, while other companies are strengthening their positions through product portfolio expansion and technological advancements.
Growing investments and collaborations among key market participants are supporting the development of advanced aesthetic devices. In May 2021, TPG Growth announced an investment in Ideal Image to support more affordable, accessible, and effective aesthetic services. In the same period, Allergan Aesthetics, an AbbVie company, signed an acquisition agreement involving Soliton and RESONIC, a Rapid Acoustic Pulse Device, supporting expansion in body contouring devices.
AbbVie Inc.
Alma Lasers
Cutera
Merz Pharma
Asclepion Laser Technologies GmbH
Implantech
Zimmer Biomet
Apyx Medical